Sort by
Refine Your Search
-
Listed
-
Employer
- University of Oxford
- ;
- KINGS COLLEGE LONDON
- Durham University
- UNIVERSITY OF VIENNA
- University of London
- DURHAM UNIVERSITY
- Heriot Watt University
- King's College London
- University of Birmingham
- University of Liverpool
- ; University of Oxford
- Aston University
- St George's University of London
- University of Cambridge
- University of Glasgow
- University of Lincoln
- 7 more »
- « less
-
Field
-
Institute for Molecular and Computational Medicine (IMCM). You will test GSK assets and targets in established models of podocyte and mesangial cell pathology relevant to glomerular diseases. You will
-
at the Faculty of Life Sciences for 6 years. The 'Molecular Targets Laboratory' led by Professor Verena M. Dirsch aims at a better understanding of the molecular mechanisms of natural products. Cell and molecular
-
for their expression in plant colonizing bacteria and integrating them into the chromosomes of appropriate chassis. Control systems will be designed to restrict expression to target plants and ensure optimal expression
-
The Role Postdoctoral Research Associate: An exploration of the relationship between funding and medal targets, and athlete experience We are seeking to appoint a Postgraduate Research Assistant
-
Institute for Renewable Energy, Department of Chemistry, University of Liverpool. This is the joint project between UK (E.P.S.R.C. funding) and USA (NSF funding). The project is targeted on an ultrasonic
-
understand drug targets and antimicrobial resistance (AMR) in Mycobacteria. MOLECULAR/COMPUTATIONAL MICROBIOLOGIST/BIOCHEMIST (Postdoctoral Research Associate) The successful candidate will develop and apply
-
the possibility of making “universal” vaccines by targeting these epitopes. We have validated this methodology for the influenza virus (https://www.nature.com/articles/s41467-018-06228-8) and the technology has
-
interpret high-resolution datasets that reveal new insights into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil
-
immunity against epitopes of limited variability (ELV), thereby opening up the possibility of making “universal” vaccines by targeting these epitopes. We have validated this methodology for the influenza
-
into disease progression, with the ultimate aim of identifying novel biomarkers and therapeutic targets. You will hold a relevant PhD/DPhil, together with relevant knowledge in normal and malignant hematopoiesis